A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects
Clinical trial NCT00117247 · COMPLETED
Trial details
- NCT number
- NCT00117247
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-06-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.